GlaxoSmithKline, the makers of Lucozade, receive many enquiries from
regarding the use of Lucozade for the Oral Glucose tolerance test, and
produce an information sheet on this topic. They normally hold a mailing
list of health professionals who have expressed an interest in this topic
over the years, and contact them if there are any changes in the formulation
which would affect its use in the OGTT. However their database has been
corrupted, and need to establish contact with those who would like to
receive updates.
If you would like to receive information in the future please contact them
by email, post or telephone, indicating if you would prefer hard copy or
electronic copy if available.
E-mail: [log in to unmask]
Address: The Nutrition Team
GlaxoSmithKline Consumer Healthcare
11 Stoke Poges Lane
Slough
Berkshire
SL1 3 NW
Tel: 01753 502132
Lanarkshire Acute Hospitals NHS Trust Disclaimer Notice
********************************************************************
The information contained in this message may be confidential
or legally privileged and is intended for the addressee only.
If you have received this message in error or there are any problems
please notify the originator immediately.
The unauthorised use,disclosure,copying or alteration of this
message is strictly forbidden.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
